DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Yau T, Hsu C, Kim TY. , et al.
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.
J Hepatol 2019;
71 (03) 543-552
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.